Progesterone in experimental permanent stroke: a dose-response and therapeutic time-window study - Wikidata - thesis-toulmin - TriplyDB

Progesterone in experimental permanent stroke: a dose-response and therapeutic time-window study

Progesterone in experimental permanent stroke: a dose-response and therapeutic time-window study

http://www.wikidata.org/entity/Q30570937

about

Embracing failure: What the Phase III progesterone studies can teach about TBI clinical trials Melatonin and Ischemic Stroke: Mechanistic Roles and Action MouseMove: an open source program for semi-automated analysis of movement and cognitive testing in rodents Ischemic conditioning-induced endogenous brain protection: Applications pre-, per- or post-stroke Progesterone for acute traumatic brain injury.Prophylactic Edaravone Prevents Transient Hypoxic-Ischemic Brain Injury: Implications for Perioperative Neuroprotection.Suboptimal Dosing Parameters as Possible Factors in the Negative Phase III Clinical Trials of Progesterone for Traumatic Brain Injury.Progesterone induces neuroprotection following reperfusion-promoted mitochondrial dysfunction after focal cerebral ischemia in rats.Progesterone exerts neuroprotective effects and improves long-term neurologic outcome after intracerebral hemorrhage in middle-aged mice Progesterone treatment in two rat models of ocular ischemia.Progesterone protects endothelial cells after cerebrovascular occlusion by decreasing MCP-1- and CXCL1-mediated macrophage infiltration.Progesterone improves long-term functional and histological outcomes after permanent stroke in older rats.The Sigma-1 Receptor Antagonist, S1RA, Reduces Stroke Damage, Ameliorates Post-Stroke Neurological Deficits and Suppresses the Overexpression of MMP-9.Neurobehavioral testing in subarachnoid hemorrhage: A review of methods and current findings in rodents.Remote Limb Preconditioning Generates a Neuroprotective Effect by Modulating the Extrinsic Apoptotic Pathway and TRAIL-Receptors Expression.Does progesterone improve outcome in diffuse axonal injury?Progesterone treatment shows greater protection in brain vs. retina in a rat model of middle cerebral artery occlusion: Progesterone receptor levels may play an important role.Neuroprotective strategies for retinal disease.A (mini) pill for stroke?

P2860

Q24273391-16442F0F-1D4E-4497-8511-333DEB43BFC2 Q26782228-A0E742F6-1CE8-4E4D-BAF1-42A2981636CF Q27307137-2A8CBB21-36A8-4940-9DC4-CAE6F42126AD Q28082979-4928AC3B-9E21-4BE6-8919-B832C2696382 Q30239996-7826E182-313E-43E2-ACAB-D890222C3ACA Q30968894-A6FBEB08-4972-4691-857F-D433F8986B44 Q33756256-B5ECFAAE-0C09-4638-8AEB-85A50782B0E8 Q33830463-D5C2C5E1-28AA-4C55-9BF7-DB50A815F0E5 Q34524885-0983663E-5372-4E4F-98E0-19427FE107BC Q35569732-A4903857-0834-4895-9FF7-AA04FE4A60ED Q36101721-C4A1565C-0826-4F0A-9A36-D5724564CE98 Q37460898-DE6A9516-D241-47BD-A5F5-01AA9E291B15 Q38639528-77F248E4-8CAF-40F7-B287-37EB0DA89471 Q38966169-B5806EAF-8E5B-43B0-8585-F260ACBA6248 Q39924636-C1B7A68F-41F0-4541-AFB0-B32F1BB0F171 Q48437787-42574ED5-2A9E-478E-BEE6-1BE6BBE52A5D Q48447425-5932CEAC-4F89-4CEC-A08D-2D88202361EC Q52372755-418CB167-3E89-45B6-9FC8-EAE88E0C6829 Q57278164-1FD8A4CE-E058-475E-BDF1-45744FD52EE0

P2860

Progesterone in experimental permanent stroke: a dose-response and therapeutic time-window study

http://www.wikidata.org/entity/Q30570937

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Progesterone in experimental p ...... therapeutic time-window study

@ast

Progesterone in experimental p ...... therapeutic time-window study

@en

type

label

Progesterone in experimental p ...... therapeutic time-window study

@ast

Progesterone in experimental p ...... therapeutic time-window study

@en

prefLabel

Progesterone in experimental p ...... therapeutic time-window study

@ast

Progesterone in experimental p ...... therapeutic time-window study

@en

P1433

Q30570937-E65DACDD-BB2F-4613-A04B-C7BE73AE3963

P1476

Q30570937-6016BF6A-84AF-4822-AFE7-C7D412D46A5B

P2093

Q30570937-5AA04062-49BC-45FE-94D0-0FDC421C84A7

Q30570937-94C539E2-127B-418E-8BF7-3BFDB357DE3E

Q30570937-A6A449CE-E855-4795-9AC0-C57D8B40CD1D

Q30570937-BE947F50-74F7-45A0-B427-480EBE5B9C34

Q30570937-F9336DCE-24E4-4668-83A8-BDA32B53EC4C

P2860

Q30570937-0328E3DD-7DE8-4A40-90FF-AFEEC023043F

Q30570937-096499E0-837E-4B1F-B237-BF71012872B8

Q30570937-0D8B2C4D-AAAC-4CB5-A364-55B2BAF7FD7B

Q30570937-0EDACF1D-85ED-41B4-AFC5-B0A8255ACFC1

Q30570937-1037295B-ADBD-4E21-B187-C07057DD094E

Q30570937-11476C0C-4FFE-4463-8141-37B83495F777

Q30570937-1AB28AA6-3E68-413B-8EA9-E8638C63975C

Q30570937-1E7F558B-461D-4AE7-92F2-A2E24B361AF5

Q30570937-24163ECC-F67B-4ABF-8306-5B1A52390679

Q30570937-299957D5-9A36-4051-B183-B0105730F5BC

P304

Q30570937-FA1604E0-49F9-471C-B39D-DAAB7470C7D5

P31

Q30570937-D042EC32-2557-4410-9D64-058D303DC759

P356

Q30570937-69D9700E-0837-4279-8986-87199FED85B8

P407

Q30570937-D35F21F3-5B6F-438E-9280-BF497AD21705

P433

Q30570937-16EFED44-D900-4A4A-9542-C30A88B2DEEF

P478

Q30570937-D8D61AEA-829E-4735-830D-7B1A858E9C43

P577

Q30570937-20A2FC8A-3D97-4F97-9CFF-D05247DB77D9

P5875

Q30570937-B06408BD-5079-4560-AEA4-143021DE215A

P698

Q30570937-BD023E93-911B-4C14-AF0C-E2754745E1BC

P932

Q30570937-758536FD-1C19-4948-9B0C-541F38E340D1

P356

P1433

P1476

Progesterone in experimental p ...... therapeutic time-window study

@en

P2093

Bushra Wali

http://www.w3.org/2001/XMLSchema#string

Donald G Stein

http://www.w3.org/2001/XMLSchema#string

Iqbal Sayeed

http://www.w3.org/2001/XMLSchema#string

Soonmi Won

http://www.w3.org/2001/XMLSchema#string

Tauheed Ishrat

http://www.w3.org/2001/XMLSchema#string

P2860

Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial

Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association

Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and disease

Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion

Heart disease and stroke statistics--2012 update: a report from the American Heart Association

Mortality by cause for eight regions of the world: Global Burden of Disease Study

Update of the stroke therapy academic industry roundtable preclinical recommendations

Neuroprotective effects of female gonadal steroids in reproductively senescent female rats.

Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia.

Allopregnanolone, a progesterone metabolite, is more effective than progesterone in reducing cortical infarct volume after transient middle cerebral artery occlusion.

P304

486-502

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/BRAIN/AWT319

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 2

http://www.w3.org/2001/XMLSchema#string

P478

137

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259490533

http://www.w3.org/2001/XMLSchema#string

P698

24374329

http://www.w3.org/2001/XMLSchema#string

P932

3914469

http://www.w3.org/2001/XMLSchema#string